Deciphera Pharmaceuticals
Waltham, US · Founded 2015 · Delaware LLC · 547 employees on LinkedIn · 3 known investors
Find your way into Deciphera Pharmaceuticals
993 people in our graph share verified history with the Deciphera Pharmaceuticals team — schools, employers, funds. One of them is your warm intro.
Mitch Kaporunlockedknows Oliver Rosen, M.D. · together at MIT Sloan School of Management (overlapped)
×4knows the team · via Mission Biocapital
×2knows the team · via University of Cologne
×2knows the team · via University of Hamburg
knows the team · via Amgen Inc.
×2knows the team · via University at Buffalo
Founders & leadership
Deciphera Pharmaceuticals was founded in 2015 by Daniel F. Flynn, Ph.D..
DF
Daniel F. Flynn, Ph.D.Founder
OR
Oliver Rosen, M.D.inExecutiveOliver Rosen is a physician-scientist with academic research focused on stem-cell transplantation and autoimmune disease treatment, who has served as an executive officer at Deciphera Pharmaceuticals and supported multiple capital rounds and public offerings totaling over $750 million.
TK
Thomas KellyExecutive
MT
Michael TaylorinExecutiveMichael Taylor is an executive and director at Deciphera Pharmaceuticals with a background in drug discovery and development, business development, and corporate management in the life sciences industry.
Board
MR
Michael RossBoard director
LR
Liam Ratcliffe, M.D., Ph.D.Board director
JM
John MartinBoard director
JA
James A. Bristol, Ph.D.Board director
DW
Dennis WalshBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$142.9M disclosed across 2 rounds · 2015–2017
▶$52.3MraisedJun 2017 · 7 investors · BiotechnologyRule 506(b)
▶$52.3MraisedJun 2017 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael RossDirector
- Oliver Rosen, M.D.Executive Officer
- Thomas KellyExecutive Officer
- Patricia L. AllenDirector
- John MartinDirector
- Daniel L. Flynn, Ph.D.Executive Officer
- Dennis WalshDirector
- James A. Bristol, Ph.D.Director
- Christopher MorlExecutive Officer
- Michael D. Taylor, Ph.D.Executive Officer, Director
- Liam Ratcliffe, M.D., Ph.D.Director
- Edward J. Benz, Jr.Director
- Offering amount
- $52.3M
- Amount sold
- $52.3M
- First sale
- May 2017
- Incorporated
- Limited Liability Company, Delaware, 2015
- Federal exemptions
- 06b
▶$90.6MraisedJul 2016 · 5 investors · PharmaceuticalsRule 506(b)
▶$90.6MraisedJul 2016 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Michael RossDirector
- Oliver Rosen, M.D.Executive Officer
- Thomas KellyExecutive Officer
- John MartinDirector
- Daniel F. Flynn, Ph.D.Executive Officer
- Liam Ratcliffe, M.D., Ph.D.Director
- Michael TaylorExecutive Officer, Director
- James A. Bristol, Ph.D.Director
- Dennis WalshDirector
- Offering amount
- $90.6M
- Amount sold
- $90.6M
- First sale
- Sep 2015
- Incorporated
- Limited Liability Company, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who founded Deciphera Pharmaceuticals?
- Deciphera Pharmaceuticals was founded by Daniel F. Flynn, Ph.D. in 2015.
- Who are Deciphera Pharmaceuticals's investors?
- Deciphera Pharmaceuticals's investors include Frazier Life Sciences, REDMILE, Viking Global Investors.
- How much funding has Deciphera Pharmaceuticals raised?
- Deciphera Pharmaceuticals has disclosed $142.9M raised across 2 rounds.
- Where is Deciphera Pharmaceuticals headquartered?
- Deciphera Pharmaceuticals is headquartered in Waltham, US.